237 related articles for article (PubMed ID: 11584063)
1. In vitro evidence for homologous recombinational repair in resistance to melphalan.
Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
[TBL] [Abstract][Full Text] [Related]
2. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
3. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
Muller C; Christodoulopoulos G; Salles B; Panasci L
Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
[TBL] [Abstract][Full Text] [Related]
4. The activity of the DNA-dependent protein kinase (DNA-PK) complex is determinant in the cellular response to nitrogen mustards.
Muller C; Calsou P; Salles B
Biochimie; 2000 Jan; 82(1):25-8. PubMed ID: 10717383
[TBL] [Abstract][Full Text] [Related]
5. The role of DNA repair in nitrogen mustard drug resistance.
Panasci L; Xu ZY; Bello V; Aloyz R
Anticancer Drugs; 2002 Mar; 13(3):211-20. PubMed ID: 11984064
[TBL] [Abstract][Full Text] [Related]
6. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
[TBL] [Abstract][Full Text] [Related]
8. After double-strand break induction by UV-A, homologous recombination and nonhomologous end joining cooperate at the same DSB if both systems are available.
Rapp A; Greulich KO
J Cell Sci; 2004 Oct; 117(Pt 21):4935-45. PubMed ID: 15367581
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.
Frit P; Canitrot Y; Muller C; Foray N; Calsou P; Marangoni E; Bourhis J; Salles B
Mol Pharmacol; 1999 Jul; 56(1):141-6. PubMed ID: 10385694
[TBL] [Abstract][Full Text] [Related]
10. The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer.
Hansen LT; Lundin C; Spang-Thomsen M; Petersen LN; Helleday T
Int J Cancer; 2003 Jul; 105(4):472-9. PubMed ID: 12712436
[TBL] [Abstract][Full Text] [Related]
11. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
[TBL] [Abstract][Full Text] [Related]
12. Potential role for the BLM helicase in recombinational repair via a conserved interaction with RAD51.
Wu L; Davies SL; Levitt NC; Hickson ID
J Biol Chem; 2001 Jun; 276(22):19375-81. PubMed ID: 11278509
[TBL] [Abstract][Full Text] [Related]
13. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
14. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells.
Nojima K; Hochegger H; Saberi A; Fukushima T; Kikuchi K; Yoshimura M; Orelli BJ; Bishop DK; Hirano S; Ohzeki M; Ishiai M; Yamamoto K; Takata M; Arakawa H; Buerstedde JM; Yamazoe M; Kawamoto T; Araki K; Takahashi JA; Hashimoto N; Takeda S; Sonoda E
Cancer Res; 2005 Dec; 65(24):11704-11. PubMed ID: 16357182
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
[TBL] [Abstract][Full Text] [Related]
16. A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.
Alagpulinsa DA; Yaccoby S; Ayyadevara S; Shmookler Reis RJ
Cancer Biol Ther; 2015; 16(6):976-86. PubMed ID: 25996477
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profile of the homologous recombination machinery and characterization of the EhRAD51 recombinase in response to DNA damage in Entamoeba histolytica.
López-Casamichana M; Orozco E; Marchat LA; López-Camarillo C
BMC Mol Biol; 2008 Apr; 9():35. PubMed ID: 18402694
[TBL] [Abstract][Full Text] [Related]
18. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
[TBL] [Abstract][Full Text] [Related]
19. Induction of alkylator (melphalan) resistance in HL60 cells is accompanied by increased levels of topoisomerase II expression and function.
Pu QQ; Bezwoda WR
Mol Pharmacol; 1999 Jul; 56(1):147-53. PubMed ID: 10385695
[TBL] [Abstract][Full Text] [Related]
20. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
